|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,432.50 JPY | +1.33% |
|
-1.06% | +11.97% |
| Market Cap | 1,128B 6.95B 6.1B 5.65B 5.19B 9.82B 665B 10.02B 67.28B 26.39B 327B 26.1B 25.52B | P/E 2027 * |
16x | P/E 2028 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 930B 5.73B 5.03B 4.66B 4.28B 8.1B 548B 8.26B 55.48B 21.76B 269B 21.52B 21.05B | EV / Sales 2027 * |
2.05x | EV / Sales 2028 * | 2.06x |
| Free-Float |
80.98% | Yield 2027 * |
3.26% | Yield 2028 * | 3.23% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +1.33% | ||
| 1 week | -1.06% | ||
| Current month | +1.86% | ||
| 1 month | +7.40% | ||
| 3 months | -1.78% | ||
| 6 months | +6.48% | ||
| Current year | +11.97% |
| 1 week | 2,386 |  | 2,507 |
| 1 month | 2,208 | | 2,507 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,579.5 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 4,107 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 76 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.33% | -1.06% | +48.46% | -4.10% | 6.95B | |
| +1.10% | +2.06% | +15.45% | +81.05% | 48.17B | |
| +0.36% | -4.47% | +66.16% | +115.81% | 35.47B | |
| +0.80% | -0.94% | -3.09% | +39.50% | 12.04B | |
| +0.20% | -1.68% | +17.05% | +90.41% | 11.79B | |
| +0.19% | +1.53% | +33.50% | +127.47% | 9.15B | |
| +0.76% | -2.36% | +18.13% | +37.03% | 6.91B | |
| +0.17% | +1.77% | +3.87% | +228.32% | 6.79B | |
| -5.52% | -11.93% | -22.06% | +7.41% | 5.77B | |
| -0.37% | +2.85% | +28.81% | +136.04% | 4.46B | |
| Average | -0.10% | -2.17% | +20.63% | +85.89% | 14.75B | |
| Weighted average by Cap. | +0.42% | -2.19% | +27.47% | +89.13% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 453B 2.79B 2.45B 2.27B 2.09B 3.95B 267B 4.02B 27.03B 10.6B 131B 10.48B 10.25B | 443B 2.73B 2.39B 2.22B 2.04B 3.86B 261B 3.93B 26.41B 10.36B 128B 10.24B 10.02B |
| Net income | 70.39B 434M 380M 352M 324M 613M 41.51B 625M 4.2B 1.65B 20.38B 1.63B 1.59B | 61.72B 380M 334M 309M 284M 538M 36.4B 548M 3.68B 1.44B 17.87B 1.43B 1.4B |
| Net Debt | -198B -1.22B -1.07B -990M -911M -1.72B -117B -1.76B -11.8B -4.63B -57.28B -4.58B -4.48B | -216B -1.33B -1.17B -1.08B -994M -1.88B -127B -1.92B -12.88B -5.05B -62.51B -4.99B -4.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | ¥2,432.50 | +1.33% | 1,327,200 |
| 26-07-13 | ¥2,400.50 | -1.13% | 1,072,800 |
| 26-07-10 | ¥2,428.00 | -0.86% | 1,422,400 |
| 26-07-09 | ¥2,449.00 | -1.61% | 1,131,700 |
| 26-07-08 | ¥2,489.00 | +1.24% | 1,453,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
